« AGS Q&A with Permaculture Capital », March 24 2025.

AGS Q&A with Permaculture Capital

Delivering and expressing modalities (therapeutic, vaccinal) to the retina by drop instillation, to the brain through intranasal drops, or the GALT, spleen and intestine by oral administration.

Ophthalmology, Oral vaccines, CNS disorders or Bowel diseases are some of AGS's verticals - or focus areas of work.

What is AGS ? What are MEVs (microalgae extracellular vesicles) and why work with them? What makes them so different from other (e.g. synthetic or animal-based) delivery systems? What are AGS's pipeline products? What advantages to the manufacturing of these ancient and simple biological mechanisms? What makes this system a sustainable, clean and economic alternative?

AGS Q&A with Permaculture Capital.

All Press Releases
«Turning Microalgae-Derived Extracellular Vesicles Into a Next-Generation Drug Delivery Platform», Genetic Engineering & Biotechnology News, February 17, 2026.
« Non-Viral delivery of innovative therapeutics »,  Immunowatch, Edition n°12, Dec 2025.
« Exosomes Europe Speaker Stories, Manuel Vega presents AGS Therapeutics », Amsterdam, NL, Nov. 3 2025.
« 15h Biotech Express : TME Pharma, AGS Therapeutics », Paris, FR, Sept. 13, 2023.
« AGS Therapeutics: The French Biotech Disrupting mRNA Delivery with Microalgae Tech », Paris, FR, Nov. 05, 2024.
« AGS Therapeutics: Pioneering Microalgae for Medicine », Business Worldwide Magazine, September 1st 2023.
« AGS Therapeutics développe un Système Universel d’Administration de Biomédicaments », Healthtech Express, mai 2023.
« AGS Therapeutics: une micro-algue au service des biomédicaments », Le Figaro Santé, décembre 2022.
« Microalgal Vesicles Deliver Therapeutics to Protected Tissues », Genetic Engineering & Biotechnology News, December 2022.
« Exosomes: Company Spotlights from “A” to “Z” », BioInformant, December 2022.
« Les microalgues organisent leur come-back », Les Deeptech, mars 2022.
« Microalgues : CAPACITÉS accompagne AGS Therapeutics et AGS-M dans leur développement. »
« Exosomes. Des biothérapies d’avenir », Pharmaceutiques n°284, février 2021.
Featured
No items found.